Diagnostics & Emerging Care Consulting
Can integrated diagnostics help you outperform your competitors by 2x?
Partners
Who Trust Us
Enabling Next-Generation Care Models with Strategic Insights
Healthcare is shifting toward ambulatory, preventive, and connected care, making diagnostics central to integrated care delivery. Organizations must balance innovation, operational efficiency, and commercialization to stay competitive.
With rising payer demand for measurable outcomes, providers seeking seamless workflow integration, and patients expecting better access, transparency, and personalization, success now depends more on partnerships, value propositions, and scalable operating models that connect diagnostics, data, and care delivery across the full care journey.
Stellarix helps organizations identify growth opportunities, strengthen portfolio strategies, and navigate clinical and regulatory complexities through market intelligence and strategic advisory.
Outpatient Care
Ambulatory Care
Diagnostic Convergence
Remote Diagnostics
Clinical Data Interoperability
Core Focus Areas
Enabling the next generation of connected, intelligent care.
Diagnostic Imaging & Radiation Systems
Imaging infrastructure is aging as providers invest in AI-enabled and connected technologies. Around 25% of CT and MRI systems have exceeded their replacement timelines, making modernization decisions increasingly strategic. We are assisting companies in streamlining their investments, equipment lifecycles, and portfolio performance.
Critical Care, Surgical & Patient Monitoring
Reliable clinical equipment is essential for uninterrupted care delivery. Manufacturers using predictive maintenance programs report up to 20% lower service costs. We are helping clients strengthen equipment reliability, lifecycle offerings, and service strategies.
Clinical & Laboratory Equipment
Automation is transforming laboratory performance. Integrated diagnostic platforms can reduce turnaround times by 30–40% while improving operational efficiency. We are supporting companies to align innovation, market access, and portfolio strategies.
Rehabilitation, Assistive & Home Healthcare
Demand for home-based care continues to grow with connected rehabilitation technologies. Integrated monitoring solutions can reduce hospital readmissions by nearly 20%. We help manufacturers strengthen product strategies and commercialization for evolving care models.
Hospital Infrastructure & Sterile Processing
Modern healthcare infrastructure is critical to patient safety and clinical efficiency. Digitally integrated sterile processing workflows reduce instrument turnaround time by up to 30%. We support organizations in modernizing infrastructure strategies and maximizing long-term asset value.
Need Strategic Guidance for Your Business?
Strategic hurdles in Diagnostics & Emerging Care
Structural pressures impacting the adoption, integration, and scalability of diagnostics and emerging care.
Fragmented Care Delivery and Integration Gaps
Care delivery is decentralizing at a rapid pace, but data remains fragmented. With 40% of patient health data remaining siloed across incompatible frameworks, it is constraining coordinated care, reducing the value of connected diagnostics, and slowing down clinical decisions.
Navigating Regulatory Complexity
Regulatory expectations are evolving in pace with emerging care technologies. With EU MDR recertification fees rising by 40% and review timelines extending to 1.5-2 years for high-risk devices, manufacturers cannot miss out on making regulatory readiness a strategic determinant of commercialization.
Demonstrating Clinical & Economic Value
Healthcare systems need stronger evidence to prove that innovation improves both affordability and outcomes. Though global healthcare spending crossed $9 trillion in 2025, only 23-25% of novel diagnostic technologies are generating the health-economic evidence needed to support broad reimbursement.
Balancing Clinical Accuracy with Operational Efficiency
Demand for faster diagnostic turnaround is rising at an unprecedented pace. However, pace should not come at the expense of clinical confidence. With the global point-of-care diagnostics market estimated to reach beyond $40 billion by 2030, companies need to improve their throughput while upholding operational reliability and diagnostic accuracy.
Accelerating Adoption Across Healthcare Ecosystems
Clinical validation alone is not enough to secure adoption. Most medical technologies typically need 12-18 months for significant market penetration because purchasing decisions rely on alignment across providers, payers, and administrators.
Scaling Interoperable and Connected Care
Integration of data across systems is a key barrier. Approx. 80% of health data from remote monitoring and wearable devices is still unused in clinical decision-making globally. With new regulatory reforms mandating interoperable data exchange and access to all acute-care equipment, the commercial viability of disconnected solutions becomes risky.
How We Drive Client Impact
Helping organizations make better strategic decisions with greater conviction.
Stellarix combines technology intelligence, innovation strategy, and IP advisory services. We guide where organizations invest, scale, and build defensible advantage through expert technology benchmarking and opportunity mapping.
Our strategic and technology intelligence has assisted clients prioritize their investments, validate technical viability, strengthen their IP positions, and scale with confidence. They uncover high-potential opportunities, anticipate competitive shifts and weak growth signals, and build innovation portfolios to turn technology choices into measurable growth.
Market intelligence, customer insights, and strategic alliances advisory that enable organizations to uncover new revenue streams, validate growth opportunities, and build partnerships before markets turn mainstream.
Sustainability ecosystem intelligence, strategy, and circular economy advisory to assist industry players in prioritizing high-impact initiatives and turning ESG commitments into tangible, lasting value.
Value and cost intelligence, operational risk & supply chain risk assessment that help companies identify hidden margin leaks and protect continuity amid rising costs and supply pressures.
Risk intelligence, regulatory advisory, and scenario planning to enable industry players to separate which disruptions matter most and build resilience across multiple possible futures.
Concept evaluation and go-to-market strategy advisory for supporting the organization in validating market readiness and accelerating commercialization from launch to scale.
Our custom dashboards turn complex data into actionable insights with advanced filters and drill-down features to track trends, competitors, performance, and opportunities in real time.
Explore more in the MedTech Industry
Discover how precision diagnostics, connected care, and next-generation medical technologies are reshaping healthcare infrastructure, clinical adoption, and competitive positioning.
Outcomes That Speak for Themselves
A leading diagnostics company sought to expand into the at-home testing segment, targeting aging populations…
A market leader in surgical robots engaged Stellarix to enhance its orthopaedic portfolio and value…
The ophthalmic medical device industry is evolving rapidly, driven by digital transformation and sustainability goals.…